Screener
T Rowe Price Group TROW Redeemable NCI
Redeemable NCI at other companies
Other financials
Where this comes from
Reported directly by T Rowe Price Group in its filing.
Tagged under the XBRL concept us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount.
The source filing: T Rowe Price Group’s 10-Q, filed April 30, 2026.
- Filed
- Apr 30, 2026, 12:41 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-028712
| Line item | 3/31/2026 | 12/31/2025 |
|---|---|---|
| Income taxes payable | 132.4 | 54.9 |
| Total liabilities | 2,517.6 | 2,288.6 |
| Commitments and contingent liabilities | ||
| Redeemable non-controlling interests | 940.2 | 1,036.0 |
| STOCKHOLDERS' EQUITY | ||
| Preferred stock, undesignated, $0.20 par value — authorized and unissued 20,000,000 shares | — | — |
| Common stock, $0.20 par value — authorized 750,000,000; issued 214,880,000 shares at March 31, 2026 and 218,565,000 at December 31, 2025 | 43.1 | 43.8 |
| Additional capital in excess of par value | — | — |
Item 1.Financial Statements.
FAQ
- What is T Rowe Price Group's redeemable NCI?
- T Rowe Price Group (TROW) reported redeemable NCI of $940.2M in Q1 2026.
- How has T Rowe Price Group's redeemable NCI changed year-over-year?
- T Rowe Price Group's redeemable NCI decreased by 3.8% year-over-year, from $977.2M to $940.2M.
- What is the long-term trend for T Rowe Price Group's redeemable NCI?
- Over 5 years (2020 to 2025), T Rowe Price Group's redeemable NCI has grown at a -7.9% compound annual growth rate (CAGR), from $1.56B to $1.04B.
- What does redeemable NCI mean?
- Minority interests in subsidiaries that include a put option allowing the minority holder to require the parent to repurchase their stake.
Ask your AI about T Rowe Price Group's redeemable nci.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude